GSK offers UK rebate if Pfizer cancer drug better

Published December 29, 2010

GSK offers UK rebate if Pfizer cancer drug better
Britain’s state-run health service will get a partial rebate from GlaxoSmithKline if the company’s new kidney cancer drug Votrient does not match up to a rival medicine in a head-to-head clinical trial.
Read more on Reuters via Yahoo! News

A year of transition at Binghamton University
It was a year of transition, healing and lingering tumult at Binghamton University.
Read more on Press & Sun-Bulletin

Study: Treatment cash saver for county, life changer for grads
WILKES-BARRE – A study conducted in October of the Luzerne County Treatment Program revealed the program has saved the county $ 4.6 million in incarceration costs during the past three years and it is expected to continue its success.
Read more on Times Leader